North East technology company Kromek is targeting 50% revenue growth after coming out of the pandemic with ‘strong momentum’.
The Sedgefield firm, which specialises in detection technology for the medical, security screening and nuclear markets, has announced revenues of £10.4m for the year ending April 30, down 21% from a year earlier.
That translated to an adjusted Ebitda loss of £1.7m, more than four times the level recorded previously, though loss before tax fell significantly to £6.3m.
Kromek Group plc designs, develops and produces x-ray and gamma-ray imaging and radiation detection products for the medical, CBRNe security, Homeland Security and civil nuclear radiation detection markets.